Integrity BioChem and ICD Group Launch ICD BioChem to Manufacture Patented IBC Bio-Based
Chemistry in Perth
Perth, Australia — September 19, 2025 — Integrity BioChem is pleased to announce a strategic
partnership with ICD BioChem, a newly formed company in the ICD Group of companies. Through this
partnership, ICD BioChem will bring Integrity BioChem’s IBC mining technology platform to the rapidly
growing Australian mining market and build local manufacturing capacity to meet strong demand for
sustainable industrial chemistries.
ICD BioChem, with operational and technical support from Integrity BioChem, is currently developing a
state-of-the-art bio-based chemical manufacturing facility in Perth. The
facility will produce the company’s patented, market-first bio-based surfactant platform in addition to
other bio-based chemistry at commercial scale to supply Australia’s mining,
industrial, HICI and personal care sectors with high-performance, lower-environmental- impact
alternatives.
“Partnering with ICD BioChem represents an important step in producing the IBC
surfactants and chemical solutions where they are needed most,” said William Gibbs, SVP Integrity
Mining and Industrial. “The IBC product line is designed to meet the rigorous performance needs in
heavy-industrial applications and reduce ecological impact — bringing local manufacturing to Australia
will help mining companies access these benefits at scale.”
ICD BioChem is committed to supporting Australia’s sustainability goals by manufacturing the IBC
chemical platform locally and tailoring solutions to the unique operational needs of Australian industry.
“We are proud to deliver a home-grown, sustainable technology that
helps the industrial sectors improve operational performance while aligning with
Australia’s environmental commitments,” said Clive Reader, Managing Director of ICD BioChem.
“Building manufacturing capability in Perth ensures reliability of supply, faster customer response, and
local economic benefits.”
Key highlights:
-
- Strategic partnership between Integrity BioChem and ICD BioChem to commercialize
the patented IBC bio-based chemical platform in Australia. - Construction of a Perth manufacturing facility to produce the platform at commercial
scale. - Technology designed for industrial, mining, Ag, HICI and personal care applications
with a focus on performance, sustainability and local supply.
About Integrity BioChem
- Strategic partnership between Integrity BioChem and ICD BioChem to commercialize
Integrity BioChem is an innovator in bio-based chemistries focused on sustainable, performance-driven
solutions for both specialty and industrial markets. The company develops patented surfactant and
formulation platforms engineered for applications
across multiple market segments with an emphasis on reducing environmental impact while improving
operational performance at a scale on par with synthetics.
About ICD Group
ICD Group is a 75-year-young, diversified specialty commodities company focused on the manufacture
and distribution of specialty metals, chemicals, and allied products. ICD combines deep technical
expertise, operational scale, and strong local partnerships to commercialize and deliver high-
performance technologies. ICD Group is committed to sustainable, customer-driven innovation and to
building reliable local supply chains that support economic growth and environmental stewardship.
Media Contacts:
Integrity BioChem
Lauren Jones
Internal Business Manager
Email: ljones@integritybiochem.com
ICD BioChem
Tigran Martayan
Business Development Manager Email: tmartayan@icdgroup.com
